ACCESS Newswire

RAUDER

8.2.2024 17:03:03 CET | ACCESS Newswire | Press release

Share
UPDATE: International Specialists Emphasized the Need for a Regulation and the Significance of Reduced Risk Options in the Comprehensive Battle Against Smoking

This release updates the previous release that posted earlier on Tuesday 6, 2024 to add more information.

PANAMA CITY, PANAMA / ACCESSWIRE / February 8, 2024 / The forum focused on promoting public health policies based on human rights and scientific evidence.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
The 2nd Nicotine and Risk Reduction was a great place to talk about problems and solutions

• Panels addressed the need for legal access to reduced-risk alternatives, such as electronic cigarettes, for millions of smokers.

• Forum's participants signed a manifesto calling on COP10 delegates to avoid prohibition and look at scientific evidence and consumers' perspectives.

Razón Autonomía Derecho A.C, RAUDER, a non-profit civil association that advocates for human rights, personal autonomy, and the free development of personality, organized the "2nd Latin American Nicotine and Risk Reduction Forum: Science, Regulation, and Activism" that took place today in Panama City. The objective was to analyze and discuss the crucial role of reduced-risk alternatives in the fight against tobacco.

The event brought together legislators, experts, doctors, scientists, and activists from across the globe. They emphasized the importance of developing public policies that aim towards harm reduction and respect for human rights, and called for a humane and effective approach, that respects consumers' rights and provides safe, science-based regulated options.

They shared different perspectives around studies and relevant practices from various countries on how alternatives such as vapor products can significantly contribute to harm reduction in smoking. Participants emphasized that their prohibition in countries such as Mexico, Brazil and Panama, has led to an increase in illegal trade and limits smokers' options to access safer alternatives.

"It is essential to recognize and regulate vapor products as reduced-risk alternatives. Prohibition not only prevents smokers from legal options but drives the black market, and gives easier access to minors, besides, all the other negative consequences that it implies," explained Rafael Lara Liy, RAUDER's director.

Doctor Marina Hoyo, a forum's panelist, said: "As health professionals, we have a responsibility to stay up to date, analyze, understand, and question the evidence. But we also need to approach our patient care from a position of empathy towards people seeking to improve their health. That's why we must consider alternatives that reduce risks. This is the foundation of a therapeutic bond that aims to truly help the individual and not stigmatize them, but rather try to alleviate their condition."

Víctor Manuel Salcedo, member of the Chamber of Representatives of Colombia, explained: "Whenever there is a health risk, regulation is necessary. We, as legislators, have the responsibility to act immediately. Our experience indicates that we should regulate, but not prohibit."

The case of other countries, such as Brazil, was also discussed. In Brazil, the ban on vapor products since 2009 has led to an uncontrolled and unsanitary illegal market, affecting millions of smokers, according to Juan José Cirión Lee, President of the organization "México y el Mundo Vapeando." We urge the Brazilian National Health Surveillance Agency (ANVISA) not to miss the opportunity to regulate alternative nicotine consumption products, considering their potential for risk reduction and respect for human rights," he added.

Studies show a significant reduction in smoking rates through reduced-risk alternatives. "The results of studies in Sweden are a clear example of what can be achieved with reduced-risk alternatives. In just 15 years, Sweden has reduced its smoking rates from 15% to 5.6% and has achieved a mortality rate from tobacco-related diseases 39.6% lower than the EU average. This success is attributed to the accessibility, acceptability, and affordability of safer alternatives, combined with balanced regulations and awareness campaigns," explained Roberto Sussman, Researcher at the UNAM Institute of Nuclear Sciences in Mexico.

RAUDER has created an online petition to strengthen the collective voice in defense of human rights, health, and legal access to nicotine alternatives. Those interested in signing the petition or supporting the cause can do so by visiting the dedicated space on the Change.org platform.

The event ended with a manifest that demands all Latin American governments to avoid prohibitions and develop science-based regulatory frameworks. "Our goal is to ensure that smokers have access to less harmful alternatives as part of a comprehensive strategy to reduce the impact of smoking on public health and that our voices are heard. This perspective is especially relevant in the context of the Tenth Conference of the Parties to the WHO Framework Convention on Tobacco Control (COP 10), taking place this week in Panama," added Rafael Lara, Director of RAUDER.

"It is important to emphasize that we share the fundamental goal of protecting public health. We advocate for the voices of consumers to be considered in discussions and decision-making that significantly impact their human rights and global health," Lara emphasized.

About RAUDER

RAUDER, short for Razón, Autonomía y Derecho, A.C., is a non-profit organization composed of experts in various fields of knowledge. Their mission is to promote and defend human rights and their respect in the daily life of society. The organization aims to influence society and public policies with the banner of respect for human rights in all aspects of social development, providing citizens with clarity about which rights they can assert concerning their governing authorities.

PRESS CONTACT:

Abroad: alejandro@nimbus.mx

Contact Information

ALEJANDRO DURAN
PR DIRECTOR
alejandro@nimbus.mx
+525534467248

SOURCE: RAUDER

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

QorusDocs Named LegalTech AI Platform of the Year and Ranked No. 1 Proposal Management Software17.11.2026 15:00:00 CET | Press release

BELLEVUE, WA / ACCESS Newswire / November 17, 2026 / QorusDocs, the pursuit intelligence platform trusted by dozens of Am Law 200 and Global 200 law firms, today announced it has been named LegalTech AI Platform of the Year in the seventh annual LegalTech Breakthrough Awards program and ranked the No. 1 proposal management solution by Info-Tech Research Group's SoftwareReviews, based on verified end-user reviews. The recognitions cap a year of rapid growth in legal for QorusDocs, which forecasts it will double its annual recurring revenue (ARR) from law firms in the next 12 months by adding more high-profile firms to its list of big law customers, which already includes DLA Piper, Baker McKenzie, Herbert Smith Freehills Kramer and Womble Bond Dickinson. Firms are moving AI beyond research and drafting and into business development, where a winning pitch depends on the best representative matters, strong attorney biographies and winning pitch strategies: knowledge general AI tools lack.

Freezz Italia Awarded ESA Contract for IRIS(2) Low-LEO Pre-Operational and De-Risk Activities17.11.2026 14:00:00 CET | Press release

CORTONA, IT / ACCESS Newswire / November 17, 2026 / Freezz Italia has been awarded a contract by the European Space Agency (ESA), as prime contractor leading a European industrial consortium, for the Consolidation Phase of the IRIS² Low-LEO Pre-Operational and De-Risk Activities, part of the ESA Programme Related to EU Secure Connectivity. The activity will further mature Friisat, Freezz's satellite system architecture conceived specifically for operation in Very Low Earth Orbit (VLEO) and designed for future broadband Direct-to-Device (D2D) connectivity within the 3GPP 5G/6G Non-Terrestrial Network (NTN) framework. Under this ESA contract, Freezz Italia will consolidate the mission and system architecture, adapting Friisat's existing commercial design to meet the requirements of an IRIS²-compatible solution, including future governmental broadband Direct-To-Device secure-connectivity services. The work will address the system and service concepts, architecture and interfaces, security

International Business Times UK Increases Programmatic Revenue by 30% with Opti Digital17.11.2026 11:00:00 CET | Press release

PARIS, FR / ACCESS Newswire / November 17, 2026 / Opti Digital, the leading AdTech company specialising in publisher revenue optimisation, today announced the results of its collaboration with International Business Times UK, an international digital news brand delivering business, markets, technology and current affairs coverage to a global readership. Operating in a fast-moving news environment, International Business Times UK continuously explores opportunities to increase the value of its digital audience while maintaining control over advertising quality and user experience. The publisher identified an opportunity to generate incremental revenue from its existing audience and inventory through a monetisation experience that could be tested progressively and scaled across a broader share of its inventory. "We were looking for ways to generate more value from our existing inventory, and the performance quickly demonstrated the potential of the new experience. It has become a meaning

OBI Pharma Signs Collaboration and License Agreement with Novartis16.11.2026 09:10:00 CET | Press release

TAIPEI, TW / ACCESS Newswire / November 16, 2026 / OBI Pharma, Inc. (4174.TWO) ("OBI") announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG ("Novartis") to develop next generation Antibody-Drug-Conjugates (ADCs) with novel payloads, using OBI's suite of platform technologies. Under the terms of the agreement, Novartis will receive worldwide rights to OBI's related patents and know-how using its ADC platform technologies on an exclusive basis for selected, undisclosed Novartis payload classes. In parallel, under the collaboration OBI will evaluate novellinker approaches with the Novartis payloads. Novartis will further have the option to expand the agreement to include additional novel payload classes. This agreement marks an important milestone for OBI and underscores the value of its differentiated ADC technology platform. The agreement recognizes the potential of OBI's proprietary technologies, including GlycOBI®, EndoSymeOBI®, HYPrOBI®, an

Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q213.11.2026 13:30:00 CET | Press release

MIAMI, FL / ACCESS Newswire / November 13, 2026 / Digi Power X Inc. (Nasdaq:DGXX)(Cboe Canada:DGX) ("Digi Power X" or the "Company"), an AI data center infrastructure operator, today reported its financial and operating results for the third quarter ended September 30, 2026 (all amounts in U.S. dollars, unless otherwise indicated). The Company's quarterly report on Form 10-Q, which includes unaudited consolidated financial statements and management's discussion and analysis ("MD&A") for the quarter ended September 30, 2026, is being filed and made accessible under the Company's continuous disclosure profile on SEDAR+ at www.sedarplus.ca and will also be available on EDGAR at www.sec.gov/edgar. Third Quarter 2026 Highlights All amounts in U.S. dollars (millions) Revenue of $12.25 million, up 85% from the previously completed fiscal quarter and an increase of 50% compared to the quarter ended September 30, 2025; $119.6 million in cash, cash equivalents and digital currencies, $103.0 mill

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye